FALSE2021Q2000183184012/31P7Y0.666600018318402021-01-012021-06-30xbrli:shares0001831840us-gaap:CommonClassAMember2021-08-050001831840us-gaap:CommonClassBMember2021-08-05iso4217:USD00018318402021-06-3000018318402020-12-310001831840semr:SeriesARedeemableConvertiblePreferredStockMember2020-12-310001831840semr:SeriesARedeemableConvertiblePreferredStockMember2021-06-300001831840semr:SeriesA1RedeemableConvertiblePreferredStockMember2020-12-310001831840semr:SeriesA1RedeemableConvertiblePreferredStockMember2021-06-30iso4217:USDxbrli:shares0001831840us-gaap:SeriesBPreferredStockMember2021-06-300001831840us-gaap:SeriesBPreferredStockMember2020-12-310001831840semr:UndesignatedPreferredStockMember2021-06-300001831840semr:UndesignatedPreferredStockMember2020-12-310001831840us-gaap:CommonClassAMember2021-06-300001831840us-gaap:CommonClassAMember2020-12-310001831840us-gaap:CommonClassBMember2021-06-300001831840us-gaap:CommonClassBMember2020-12-3100018318402021-04-012021-06-3000018318402020-04-012020-06-3000018318402020-01-012020-06-300001831840us-gaap:RetainedEarningsMember2021-04-012021-06-300001831840semr:SeriesARedeemableConvertiblePreferredStockMember2019-12-310001831840semr:SeriesA1RedeemableConvertiblePreferredStockMember2019-12-310001831840us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2019-12-310001831840us-gaap:CommonStockMember2019-12-310001831840us-gaap:CommonClassAMemberus-gaap:CommonStockMember2019-12-310001831840us-gaap:CommonClassBMemberus-gaap:CommonStockMember2019-12-310001831840us-gaap:AdditionalPaidInCapitalMember2019-12-310001831840us-gaap:RetainedEarningsMember2019-12-3100018318402019-12-310001831840us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-3100018318402020-01-012020-03-310001831840us-gaap:RetainedEarningsMember2020-01-012020-03-310001831840semr:SeriesARedeemableConvertiblePreferredStockMember2020-03-310001831840semr:SeriesA1RedeemableConvertiblePreferredStockMember2020-03-310001831840us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2020-03-310001831840us-gaap:CommonStockMember2020-03-310001831840us-gaap:CommonClassAMemberus-gaap:CommonStockMember2020-03-310001831840us-gaap:CommonClassBMemberus-gaap:CommonStockMember2020-03-310001831840us-gaap:AdditionalPaidInCapitalMember2020-03-310001831840us-gaap:RetainedEarningsMember2020-03-3100018318402020-03-310001831840us-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-300001831840us-gaap:RetainedEarningsMember2020-04-012020-06-300001831840semr:SeriesARedeemableConvertiblePreferredStockMember2020-06-300001831840semr:SeriesA1RedeemableConvertiblePreferredStockMember2020-06-300001831840us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2020-06-300001831840us-gaap:CommonStockMember2020-06-300001831840us-gaap:CommonClassAMemberus-gaap:CommonStockMember2020-06-300001831840us-gaap:CommonClassBMemberus-gaap:CommonStockMember2020-06-300001831840us-gaap:AdditionalPaidInCapitalMember2020-06-300001831840us-gaap:RetainedEarningsMember2020-06-3000018318402020-06-300001831840us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2020-12-310001831840us-gaap:CommonStockMember2020-12-310001831840us-gaap:CommonClassAMemberus-gaap:CommonStockMember2020-12-310001831840us-gaap:CommonClassBMemberus-gaap:CommonStockMember2020-12-310001831840us-gaap:AdditionalPaidInCapitalMember2020-12-310001831840us-gaap:RetainedEarningsMember2020-12-310001831840semr:SeriesARedeemableConvertiblePreferredStockMember2021-01-012021-03-310001831840semr:SeriesA1RedeemableConvertiblePreferredStockMember2021-01-012021-03-310001831840us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2021-01-012021-03-310001831840us-gaap:CommonStockMember2021-01-012021-03-310001831840us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-3100018318402021-01-012021-03-310001831840us-gaap:CommonClassAMember2021-01-012021-03-310001831840us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-01-012021-03-310001831840us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-01-012021-03-310001831840us-gaap:RetainedEarningsMember2021-01-012021-03-310001831840semr:SeriesARedeemableConvertiblePreferredStockMember2021-03-310001831840semr:SeriesA1RedeemableConvertiblePreferredStockMember2021-03-310001831840us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2021-03-310001831840us-gaap:CommonStockMember2021-03-310001831840us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-03-310001831840us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-03-310001831840us-gaap:AdditionalPaidInCapitalMember2021-03-310001831840us-gaap:RetainedEarningsMember2021-03-3100018318402021-03-310001831840us-gaap:CommonClassAMember2021-04-012021-06-300001831840us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-04-012021-06-300001831840us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001831840us-gaap:CommonClassBMember2021-04-012021-06-300001831840us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-04-012021-06-300001831840us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2021-06-300001831840us-gaap:CommonStockMember2021-06-300001831840us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-06-300001831840us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-06-300001831840us-gaap:AdditionalPaidInCapitalMember2021-06-300001831840us-gaap:RetainedEarningsMember2021-06-300001831840us-gaap:CommonClassAMemberus-gaap:IPOMember2021-03-292021-03-290001831840us-gaap:CommonClassAMemberus-gaap:IPOMember2021-03-290001831840us-gaap:CommonClassBMember2021-01-012021-06-300001831840us-gaap:CommonClassAMemberus-gaap:OverAllotmentOptionMember2021-04-232021-04-2300018318402021-07-012021-06-3000018318402021-01-012020-12-31semr:vote0001831840us-gaap:CommonClassAMember2021-01-012021-06-300001831840us-gaap:EmployeeStockOptionMember2021-04-012021-06-300001831840us-gaap:EmployeeStockOptionMember2020-04-012020-06-300001831840us-gaap:EmployeeStockOptionMember2021-01-012021-06-300001831840us-gaap:EmployeeStockOptionMember2020-01-012020-06-300001831840us-gaap:RestrictedStockUnitsRSUMember2021-04-012021-06-300001831840us-gaap:RestrictedStockUnitsRSUMember2020-04-012020-06-300001831840us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-06-300001831840us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-06-300001831840us-gaap:EmployeeStockOptionMember2021-04-012021-06-300001831840us-gaap:EmployeeStockOptionMember2020-04-012020-06-300001831840us-gaap:EmployeeStockOptionMember2021-01-012021-06-300001831840us-gaap:EmployeeStockOptionMember2020-01-012020-06-300001831840us-gaap:PreferredStockMember2021-04-012021-06-300001831840us-gaap:PreferredStockMember2020-04-012020-06-300001831840us-gaap:PreferredStockMember2021-01-012021-06-300001831840us-gaap:PreferredStockMember2020-01-012020-06-300001831840us-gaap:RestrictedStockUnitsRSUMember2021-04-012021-06-300001831840us-gaap:RestrictedStockUnitsRSUMember2020-04-012020-06-300001831840us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-06-300001831840us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-06-300001831840us-gaap:ComputerEquipmentMember2021-06-300001831840us-gaap:ComputerEquipmentMember2020-12-310001831840us-gaap:FurnitureAndFixturesMember2021-06-300001831840us-gaap:FurnitureAndFixturesMember2020-12-310001831840us-gaap:LeaseholdImprovementsMember2021-06-300001831840us-gaap:LeaseholdImprovementsMember2020-12-310001831840us-gaap:CapitalLeaseObligationsMember2021-06-300001831840us-gaap:CapitalLeaseObligationsMember2020-12-31semr:investment00018318402021-01-012021-01-31xbrli:pure00018318402021-01-310001831840semr:ProwlyMember2020-08-270001831840semr:ProwlyMember2020-08-272020-08-270001831840us-gaap:TechnologyBasedIntangibleAssetsMember2021-06-300001831840us-gaap:TradeNamesMember2021-06-300001831840us-gaap:SoftwareDevelopmentMember2021-06-300001831840us-gaap:TechnologyBasedIntangibleAssetsMember2020-12-310001831840us-gaap:TradeNamesMember2020-12-310001831840us-gaap:SoftwareDevelopmentMember2020-12-310001831840us-gaap:SoftwareDevelopmentMember2021-04-012021-06-300001831840us-gaap:SoftwareDevelopmentMember2021-01-012021-06-300001831840us-gaap:SoftwareDevelopmentMember2020-04-012020-06-300001831840us-gaap:SoftwareDevelopmentMember2020-01-012020-06-300001831840us-gaap:RevolvingCreditFacilityMembersemr:JPMorganChaseMembersemr:JPMorganChaseCreditAgreementMember2021-01-120001831840us-gaap:LetterOfCreditMembersemr:JPMorganChaseMembersemr:JPMorganChaseCreditAgreementMember2021-01-120001831840us-gaap:RevolvingCreditFacilityMembersemr:JPMorganChaseMembersemr:JPMorganChaseCreditAgreementMember2021-01-122021-01-120001831840us-gaap:RevolvingCreditFacilityMembersemr:JPMorganChaseMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-01-120001831840us-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMembersemr:JPMorganChaseMember2021-01-120001831840us-gaap:RevolvingCreditFacilityMembersemr:JPMorganChaseMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-01-122021-01-120001831840us-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMembersemr:JPMorganChaseMember2021-01-122021-01-120001831840us-gaap:RevolvingCreditFacilityMembersemr:JPMorganChaseMember2021-01-122021-01-120001831840us-gaap:RevolvingCreditFacilityMembersemr:JPMorganChaseMember2021-04-012021-06-300001831840us-gaap:RevolvingCreditFacilityMembersemr:JPMorganChaseMember2021-01-012021-06-3000018318402021-03-280001831840semr:SeriesARedeemableConvertiblePreferredStockMember2021-03-280001831840semr:SeriesA1RedeemableConvertiblePreferredStockMember2021-03-280001831840us-gaap:SeriesBPreferredStockMember2021-03-2800018318402021-03-282021-03-2800018318402021-03-152021-03-150001831840us-gaap:EmployeeStockOptionMember2021-06-300001831840us-gaap:EmployeeStockMember2021-06-300001831840us-gaap:RestrictedStockMember2021-06-300001831840us-gaap:RestrictedStockUnitsRSUMember2021-06-300001831840semr:A2019StockOptionAndGrantPlanMember2019-12-310001831840semr:A2019StockOptionAndGrantPlanMember2020-07-310001831840semr:A2019StockOptionAndGrantPlanMember2020-07-012020-07-310001831840semr:A2021StockOptionAndIncentivePlanMember2021-06-300001831840semr:A2021StockOptionAndIncentivePlanMember2021-01-012021-06-300001831840us-gaap:CostOfSalesMember2021-04-012021-06-300001831840us-gaap:CostOfSalesMember2020-04-012020-06-300001831840us-gaap:CostOfSalesMember2021-01-012021-06-300001831840us-gaap:CostOfSalesMember2020-01-012020-06-300001831840us-gaap:SellingAndMarketingExpenseMember2021-04-012021-06-300001831840us-gaap:SellingAndMarketingExpenseMember2020-04-012020-06-300001831840us-gaap:SellingAndMarketingExpenseMember2021-01-012021-06-300001831840us-gaap:SellingAndMarketingExpenseMember2020-01-012020-06-300001831840us-gaap:ResearchAndDevelopmentExpenseMember2021-04-012021-06-300001831840us-gaap:ResearchAndDevelopmentExpenseMember2020-04-012020-06-300001831840us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-06-300001831840us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-06-300001831840us-gaap:GeneralAndAdministrativeExpenseMember2021-04-012021-06-300001831840us-gaap:GeneralAndAdministrativeExpenseMember2020-04-012020-06-300001831840us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-06-300001831840us-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-06-3000018318402020-01-012020-12-310001831840us-gaap:RestrictedStockMember2020-07-282020-07-280001831840us-gaap:RestrictedStockUnitsRSUMember2020-12-310001831840us-gaap:EmployeeStockMember2021-01-012021-06-300001831840us-gaap:EquipmentMember2021-06-300001831840us-gaap:CapitalLeaseObligationsMember2021-01-012021-06-300001831840semr:CurrentCapitalLeaseObligationsMember2021-06-300001831840semr:NonCurrentCapitalLeaseObligationsMember2021-06-300001831840semr:DataProviderMember2021-06-30semr:segment0001831840country:US2021-04-012021-06-300001831840country:US2020-04-012020-06-300001831840country:US2021-01-012021-06-300001831840country:US2020-01-012020-06-300001831840country:GB2021-04-012021-06-300001831840country:GB2020-04-012020-06-300001831840country:GB2021-01-012021-06-300001831840country:GB2020-01-012020-06-300001831840semr:OtherGeographicalAreaMember2021-04-012021-06-300001831840semr:OtherGeographicalAreaMember2020-04-012020-06-300001831840semr:OtherGeographicalAreaMember2021-01-012021-06-300001831840semr:OtherGeographicalAreaMember2020-01-012020-06-300001831840country:US2021-06-300001831840country:US2020-12-310001831840country:RU2021-06-300001831840country:RU2020-12-310001831840country:CZ2021-06-300001831840country:CZ2020-12-310001831840semr:OtherGeographicalAreaMember2021-06-300001831840semr:OtherGeographicalAreaMember2020-12-31

        
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
            
    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2021
OR
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 001-40276
Semrush Holdings, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware84-4053265
(State or Other Jurisdiction of
Incorporation or Organization)
(I.R.S. Employer
Identification Number)
800 Boylston Street, Suite 2475
Boston, MA 02199
(Address of principal executive offices including zip code)

(800) 851-9959
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:        
Title of each classTrading symbol(s)Name of each exchange on which registered
Class A Common Stock, $0.00001 par value per shareSEMRThe New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes or ☐ No.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes or ☐ No.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company
                                    
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes or No
As of August 5, 2021, there were 10,800,368 shares of the registrant’s Class A Common Stock and 124,696,442 shares of the registrant’s Class B Common Stock, $0.00001 par value per share, outstanding.




TABLE OF CONTENTS

Page
Part I. Financial Information
Item 1.
Item 2.
Item 3.
Item 4.
Part II. Other Information
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.







SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains forward-looking statements about Semrush Holdings, Inc. (“Semrush Holdings”) and our subsidiaries (collectively, the “Group”, the “Company”, “Semrush”, “we”, “us”, or “our”) and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would,” or the negative of these words or other similar terms or expressions. Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to, statements about:
•our future financial performance, including our revenue, annual recurring revenue (“ARR”), costs of revenue, gross profit or gross margin and operating expenses;
•the sufficiency of our cash and cash equivalents to meet our liquidity needs;
•anticipated trends and growth rates in our business and in the markets in which we operate;
•our ability to maintain the security and availability of our internal networks and platform;
•our ability to attract new paying customers and convert free customers into paying customers;
•our ability to retain and expand sales to our existing paying customers, including upgrades to premium subscriptions, purchases of add-on offerings, and increasing the number of authorized users per paying customer;
•our ability to access, collect, and analyze data;
•our ability to successfully expand in our existing markets and into new markets;
•our ability to effectively manage our growth and future expenses;
•our ability to continue to innovate and develop new products and features, improve our data assets, and enhance our technological capabilities;
•our estimated total addressable market;
•our ability to maintain, protect, and enhance our intellectual property;
•our ability to comply with modified or new laws and regulations applying to our business;
•the attraction and retention of qualified employees and key personnel;
•our anticipated investments in sales and marketing, and research and development;
•our ability to successfully defend litigation brought against us;
•our ability to successfully acquire and integrate companies and assets;
•the increased expenses associated with being a public company;
i


•our use of the net proceeds from our initial public offering (“IPO”); and
•the impact of the novel strain of coronavirus (“COVID-19”) on our business and industry.
You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operations and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors described in the section titled “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report on Form 10-Q. The results, events, and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements.
The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make.
In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Quarterly Report on Form 10-Q, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and you are cautioned not to unduly rely upon these statements.
ii

PART 1 - FINANCIAL INFORMATION
Item 1. Financial Statements
SEMRUSH HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data)

As of
June 30, 2021December 31, 2020
Assets
Current assets
Cash and cash equivalents$180,759 $35,531 
Accounts receivable2,722 1,399 
Deferred contract costs, current portion5,418 4,049 
Prepaid expenses and other current assets7,180 2,649 
Total current assets196,079 43,628 
Property and equipment, net8,396 2,968 
Intangible assets, net2,127 2,231 
Goodwill1,991 1,991 
Deferred contract costs, net of current portion2,140 1,670 
Other long-term assets1,026 2,470 
Total assets$211,759 $54,958 
Liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)
Current liabilities
Accounts payable$9,135 $8,654 
Accrued expenses12,847 7,719 
Deferred revenue34,652 26,537 
Other current liabilities1,859  
Total current liabilities58,493 42,910 
Long-term liabilities
Deferred revenue, net of current portion237 123 
Deferred tax liability126 209 
Other long-term liabilities3,438 497 
Total liabilities62,294 43,739 
Commitments and contingencies (Note 11)
Series A redeemable convertible preferred stock, $0.00001 par value - no shares authorized, issued or outstanding as of June 30, 2021; 3,379,400 shares authorized, issued and outstanding as of December 31, 2020 (liquidation value of $8,000 at December 31, 2020)
 7,789 
Series A-1 redeemable convertible preferred stock, $0.00001 par value - no shares authorized, issued or outstanding as of June 30, 2021; 1,837,600 shares authorized, issued and outstanding as of December 31, 2020 (liquidation value of $5,000 at December 31, 2020)
 10,270 
Stockholders' equity (deficit)
Series B convertible preferred stock, $0.00001 par value - no shares authorized, issued or outstanding as of June 30, 2021; 4,681,400 shares authorized, issued and outstanding as of December 31, 2020 (liquidation value of $24,000 at December 31, 2020)
 24,000 
Undesignated preferred stock, $0.00001 par value - 100,000,000 shares authorized, and no shares issued or outstanding as of June 30, 2021; no shares authorized, issued, or outstanding as of December 31, 2020
  
Common stock, $0.00001 par value - no shares authorized, issued, or outstanding as of June 30, 2021; 300,000,000 shares authorized, and 95,206,893 shares issued and 95,050,041 shares outstanding at December 31, 2020
  
Class A common stock, $0.00001 par value - 1,000,000,000 shares authorized, and 10,800,368 shares issued and outstanding as of June 30, 2021; no shares authorized, issued or outstanding as of December 31, 2020
  
Class B common stock, $0.00001 par value - 160,000,000 shares authorized, and 124,905,954 shares issued and 124,696,442 outstanding as of June 30, 2021; no shares authorized, issued or outstanding as of December 31, 2020
1  
Additional paid-in capital 184,087 4,975 
Accumulated deficit(34,623)(35,815)
Total stockholders’ equity (deficit) 149,465 (6,840)
Total liabilities, redeemable convertible preferred stock, and stockholders' equity (deficit)$211,759 $54,958 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
1


SEMRUSH HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
(in thousands, except per share data)

Three Months Ended
June 30,
Six Months Ended
June 30,
2021202020212020
Revenue$45,005 $28,452 $85,003 $56,239 
Cost of revenue10,238 7,055 19,011 13,666 
Gross profit34,767 21,397 65,992 42,573 
Operating expenses
Sales and marketing18,298 12,704 34,755 25,581 
Research and development5,964 4,001 11,322 8,238 
General and administrative10,520 6,570 18,424 12,503 
Total operating expenses34,782 23,275 64,501 46,322 
Income (loss) from operations(15)(1,878)1,491 (3,749)
Other expense, net(123)(138)(72)(82)
Income (loss) before income taxes(138)(2,016)1,419 (3,831)
Provision for income taxes141 92 227 208 
Net income (loss)$(279)$(2,108)$1,192 $(4,039)
Net income (loss) per share attributable to common stockholders:
Basic and diluted$0.00 $(0.02)$0.01 $(0.04)
Weighted-average number of shares of common stock used in computing net income (loss) per share attributable to common stockholders:
Basic135,312 94,738 115,951 94,666 
Diluted135,312 94,738 137,263 94,666 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
2


SEMRUSH HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)
(in thousands, except share data)

Series ASeries A-1Series BCommon StockClass A Common StockClass B Common Stock
Additional
Paid-in
Capital
Accumulated
Deficit
Total
Stockholders’
Equity
(Deficit)
SharesAmountSharesAmountSharesAmountSharesAmountSharesAmountSharesAmount
Balances at December 31, 20193,379,400 $7,789 1,837,600 $10,270 4,681,400 $24,000 94,592,700 $  $  $ $3,644 $(28,803)$(1,159)
Stock-based compensation expense— — — — — — — — — — — — 205 — 205 
Net loss— — — — — — — — — — — — — (1,931)(1,931)
Balances at March 31, 20203,379,400 7,789 1,837,600 10,270 4,681,400 24,000 94,592,700      3,849 (30,734)(2,885)
Stock-based compensation expense— — — — — — — — — — — — 209 — 209 
Net loss— — — — — — — — — — — — — (2,108)(2,108)
Balances at June 30, 20203,379,400 $7,789 1,837,600 $10,270 4,681,400 $24,000 94,592,700 $  $  $ $4,058 $(32,842)$(4,784)
Balances at December 31, 2020
3,379,400 $7,789 1,837,600 $10,270 4,681,400 $24,000 95,050,041 $  $  $ 4,975 (35,815)$(6,840)
Conversion of Preferred Stock(3,379,400)(7,789)(1,837,600)(10,270)(4,681,400)(24,000)29,695,200 — — — — — 42,058 — 18,058 
Issuance of Class A Common Stock in connection with the initial public offering, net of $13,378 in issuance costs
— — — — — — — — 10,000,000 — — — 126,622 — 126,622 
Reclassification of Common Stock to Class B Common Stock in connection with the initial public offering— — — — — — (124,745,241)— — — 124,745,241 1 (1)—  
Exercise of stock options, net of shares withheld for employee taxes— — — — — — — — — — 3,861 — 7 — 7 
Stock-based compensation expense— — — — — — — — — — — — 593 — 593 
Net Income— — — — — — — — — — — — — 1,471 1,471 
Balances at March 31, 2021        10,000,000  124,749,102 1 174,254 (34,344)139,911 
Issuance of Class A Common Stock in connection with the partial exercise of the overallotment option in connection with the initial public offering, net of $825 in issuance costs
— — — — — — — — 719,266 — — — 9,245 — 9,245 
Conversion of Class B Common Stock to Class A Common Stock— — — — — — — — 81,102 — (81,102)— — — — 
Exercise of stock options, net of shares withheld for employee taxes— — — — — — — — — — 28,442 — 19 — 19 
Stock-based compensation— — — — — — — — — — — — 569 — 569 
Net Income— — — — — — — — — — — — — (279)(279)
Balances at June 30, 2021 $  $  $  $ 10,800,368 $ 124,696,442 $1 $184,087 $(34,623)$149,465 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
3


SEMRUSH HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

Six Months Ended
June 30,
20212020
Operating Activities
Net income (loss)$1,192 $(4,039)
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation and amortization expense1,447 474 
Amortization of deferred contract costs2,950 2,259 
Stock-based compensation expense1,162 414 
Non-cash interest expense104  
Deferred taxes(83)(108)
Changes in operating assets and liabilities
Accounts receivable(1,324)603 
Deferred contract costs(4,789)(3,114)
Prepaid expenses and other current assets(4,530)(788)
Accounts payable720 438 
Accrued expenses4,981 2,589 
Deferred revenue8,229 2,233 
Net cash provided by operating activities10,059 961 
Investing Activities
Purchases of property and equipment(750)(1,792)
Purchases of convertible debt securities(500) 
Capitalization of internal-use software development costs(271)(700)
Cash paid for acquisition of business, net of cash acquired(350) 
Net cash used in investing activities(1,871)(2,492)
Financing Activities
Proceeds from exercise of stock options26  
Net proceeds from completing initial public offering137,467  
Payment of capital leases(453) 
Payment of deferred offering costs (38)
Net cash provided by (used in) financing activities 137,040 (38)
Increase in cash, cash equivalents and restricted cash145,228 (1,569)
Cash, cash equivalents and restricted cash, at beginning of period35,619 37,523 
Cash, cash equivalents and restricted cash, at end of period$180,847 $35,954 
Supplemental cash flow disclosures
Cash paid for interest$112 $ 
Cash paid for income taxes$232 $457 
Acquisition of fixed asset under capital lease$5,750 $ 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
4


SEMRUSH HOLDINGS, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Three and Six Months Ended June 30, 2021 and 2020
(in thousands, except share and per share data, unless otherwise noted)
1.Overview and Basis of Presentation
Description of Business
Semrush Holdings, Inc. (“Semrush Holdings”) and its subsidiaries (together the “Group”, the “Company”, or “Semrush”) provide an online visibility management software-as-a-service (“SaaS”) platform. The Company’s platform enables its subscribers to improve their online visibility and drive traffic, including on their websites and social media pages, and distribute highly relevant content to their customers on a targeted basis across various channels to drive high-quality traffic and measure the effectiveness of their digital marketing campaigns. The Company is headquartered in Boston, Massachusetts, and has wholly owned subsidiaries in Cyprus, Russia, the Czech Republic, Poland, and the United States.
The Company is subject to a number of risks and uncertainties common to companies in similar industries and stages of development that could affect future operations and financial performance. These risks include, but are not limited to, rapid technological change, competitive pressure from substitute products or larger companies, protection of proprietary technology, management of international activities, the need to obtain additional financing to support growth, and dependence on third parties and key individuals.
2019 Reorganization
On December 19, 2019, Semrush Holdings was incorporated in the state of Delaware and entered into a Contribution and Exchange Agreement with SEMrush CY Ltd (“SEMrush CY”) (a private limited liability company organized under the Cyprus Companies Law, Cap 113), pursuant to which the holders of all outstanding shares of capital stock of SEMrush CY contributed those shares to Semrush Holdings in exchange for identical shares of capital stock of Semrush Holdings (the “2019 Share Exchange”). Upon the 2019 Share Exchange, Semrush Holdings became the holding company of SEMrush CY and its wholly owned subsidiaries and the historical consolidated financial statements of SEMrush CY became the historical consolidated financial statements of Semrush Holdings. The 2019 Share Exchange and related transactions were completed on December 27, 2019.
Initial Public Offering
On March 29, 2021, the Company closed its initial public offering (“IPO”) in which it sold 10,000,000 shares of its Class A common stock at a price to the public of $14.00 per share. The Company received $126.6 million in net proceeds after deducting approximately $13.4 million for underwriting discounts, commissions and offering expenses. Immediately prior to the completion of the IPO, all shares of common stock then outstanding were reclassified as Class B common stock, and all shares of redeemable convertible preferred stock and convertible preferred stock then outstanding were converted into shares of common stock on a one-to-one basis and then reclassified into Class B common stock.
On April 20, 2021, the underwriters of the Company’s IPO partially exercised their option to purchase additional shares of Class A common stock. In connection with the closing of the partial exercise on April 23, 2021, the underwriters purchased 719,266 shares of the Company’s Class A common stock for net
5


proceeds to the Company of $9.2 million after deducting approximately $0.8 million for underwriting discounts, commissions, and offering expenses.
Effects of COVID-19
The Company considered the potential effects of the novel strain of coronavirus (“COVID-19”) pandemic on the Company. In March 2020, the World Health Organization declared the outbreak of COVID-19 a pandemic, and numerous new strains of COVID-19 have subsequently spread throughout the world. COVID-19 has continued to impact market and economic conditions globally. In an attempt to limit the spread of the virus, various governmental restrictions have been implemented, including restrictions with respect to business activities and travel restrictions, and “shelter–at–home” orders, that have had and may continue to have an adverse impact on the Company’s business and operations. In light of the evolving nature of COVID-19 and the uncertainty it has produced around the world, it is not possible to predict the COVID-19 pandemic’s cumulative and ultimate impact on the Company’s future business operations, results of operations, financial position, liquidity, and cash flows. The extent of the impact of the pandemic on the Company’s business and financial results will depend largely on future developments, including the duration of the spread of the outbreak both globally and within the U.S., the impact on capital, foreign currencies exchange and financial markets, and governmental or regulatory orders that impact the Company’s business, all of which are highly uncertain and cannot be predicted.
As of June 30, 2021, the Company has experienced long lead times for hardware affected by a semiconductor shortage attributed to the COVID-19 pandemic which may affect its ability to fully furnish the infrastructure within its data centers. The Company will continue to actively monitor the current international and domestic impacts of and responses to COVID-19 and its related risks.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Any reference in these notes to applicable guidance is meant to refer to the authoritative United States generally accepted accounting principles as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”).
The unaudited condensed consolidated interim financial statements have been prepared on the same basis as the audited annual consolidated financial statements as of and for the year ended December 31, 2020, and, in the opinion of management, reflect all adjustments, consisting of normal recurring adjustments, necessary for the fair presentation of the Company’s financial position as of June 30, 2021, and the results of its operations and its cash flows for the three and six months ended June 30, 2021 and 2020. The consolidated balance sheet as of December 31, 2020 included herein was derived from the audited financial statements as of that date.
The results for the three and six months ended June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021, any other interim periods, or any future year or period.
The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s final prospectus dated March 24, 2021 (the “Prospectus”) as filed with the SEC on March 25, 2021 pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the “Securities Act”).
6


The accompanying unaudited condensed consolidated financial statements reflect the application of certain significant accounting policies as described below and elsewhere in these notes to the unaudited condensed consolidated financial statements. As of June 30, 2021, there have been no material changes in the Company's significant accounting policies from those that were disclosed in the Prospectus except as discussed below.
2.Summary of Significant Accounting Policies
Principles of Consolidation
The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant estimates relied upon in preparing these financial statements include, but are not limited to, revenue recognition, expected future cash flows used to evaluate the recoverability of long-lived assets, contingent liabilities, expensing and capitalization of research and development costs for internal-use software, the average period of benefit associated with costs capitalized to obtain revenue contracts, the determination of the fair value of stock-based awards issued, stock-based compensation expense, and the recoverability of the Company’s net deferred tax assets and related valuation allowance.
Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Actual results may differ from management’s estimates if these results differ from historical experience, or other assumptions do not turn out to be substantially accurate, even if such assumptions are reasonable when made.
Subsequent Events Considerations
The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that require additional disclosure. Subsequent events have been evaluated as required. The Company has evaluated all subsequent events and determined that there are no material recognized or unrecognized subsequent events requiring disclosure, other than those disclosed in this Quarterly Report on Form 10-Q.
Emerging Growth Company Status
The Company is an "emerging growth company," as defined in the Jumpstart Our Business Startups Act, or JOBS Act, and may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not "emerging growth companies." The Company may take advantage of these exemptions until the Company is no longer an "emerging growth company." Section 107 of the JOBS Act provides that an "emerging growth company" can take advantage of the extended transition period afforded by the JOBS Act for the implementation of new or revised accounting standards. The Company has elected to use the extended transition period for complying with new or revised accounting standards and, as a result of this election, its financial statements may not be comparable to companies that comply with public company effective dates. The Company may take
7


advantage of these exemptions up until the last day of the year following the fifth anniversary of an offering or such earlier time that it is no longer an emerging growth company. The Company would cease to be an emerging growth company if it has more than $1.07 billion in annual revenue, has more than $700.0 million in market value of its stock held by non-affiliates (and it has been a public company for at least 12 months, and has filed one annual report on Form 10-K), or it issues more than $1.0 billion of non-convertible debt securities over a three-year period.
Revenue Recognition
The Company derives revenue from two sources: (1) subscription revenues via the Semrush Online Visibility Management Platform and the Prowly Public Relations Platform, which are comprised of subscription fees from customers accessing the Company’s SaaS services and related customer support; and (2) the Semrush Marketplace, which allows customers to pay a set fee for services or products offered through the marketplace.
The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”). Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration it expects to receive in exchange for those products or services. There were no changes to the Company’s revenue recognition policies since the filing of the Prospectus.
For the three and six months ended June 30, 2021 and 2020, subscription revenue accounted for nearly all of the Company’s revenue. Revenue related to the Semrush Marketplace was not material for the three and six months ended June 30, 2021 and 2020.
Amounts that have been invoiced are recorded in accounts receivable and in deferred revenue or revenue, depending on whether the revenue recognition criteria have been met. The Company primarily invoices and collects payments from customers for its services in advance on a monthly or annual basis.
Deferred revenue represents amounts billed for which revenue has not yet been recognized. Deferred revenue that will be recognized during the succeeding 12-month period is recorded as current deferred revenue, and the remaining portion is recorded as long-term deferred revenue. Deferred revenue increased by $8,229 as of June 30, 2021 compared December 31, 2020. During the three months ended June 30, 2021 and 2020, $15,617 and $10,456 of revenue was recognized that was included in deferred revenue at the beginning of each respective period. During the six months ended June 30, 2021 and 2020, $20,164 and $14,633 of revenue was recognized that was included in deferred revenue at the beginning of each respective period.
The Company has elected to exclude amounts charged to customers for sales tax from the transaction price. Accordingly, revenue is presented net of any sales tax collected from customers.
Transaction Price Allocated to Future Performance Obligations
ASC 606 requires that the Company disclose the aggregate amount of the transaction price that is allocated to performance obligations that have not yet been satisfied as of the balance sheet dates reported.
For contracts with an original expected duration greater than one year, the aggregate amount of the transaction price allocated to the performance obligations that were unsatisfied as of June 30, 2021 and December 31, 2020 was $504 and $1,280, respectively, which the Company expects to recognize over the next 12 months.
For contracts with an original expected duration of one year or less, the Company has applied the practical expedient available under ASC 606 to not disclose the amount of transaction price allocated to
8


unsatisfied performance obligations as of June 30, 2021 and December 31, 2020. For performance obligations not satisfied as of June 30, 2021 and December 31, 2020, and to which this expedient applies, the nature of the performance obligations is consistent with performance obligations satisfied as of December 31, 2019. The remaining durations are less than one year.
Costs to Obtain a Contract
The incremental direct costs of obtaining a contract, which primarily consist of sales commissions paid for new subscription contracts, are deferred and recorded as deferred contract costs in the consolidated balance sheet and are amortized over a period of approximately 24 months on a systematic basis, consistent with the pattern of transfer of the goods or services to which the asset relates. The 24-month period represents the estimated benefit period of the customer relationship and has been determined by taking into consideration the type of product sold, the commitment term of the customer contract, the nature of the Company’s technology development life-cycle, and an estimated customer relationship period based on historical experience and future expectations. Sales commissions for renewals and upgrade contracts are deferred and amortized on a straight-line basis over the remaining estimated customer relationship period of the related customer. Deferred contract costs that will be recorded as expense during the succeeding 12-month period are recorded as current deferred contract costs, and the remaining portion is recorded as deferred contract costs, net of current portion. Amortization of deferred contract costs is included in sales and marketing expense in the accompanying consolidated statement of operations and comprehensive income (loss).
Cash, Cash Equivalents, and Restricted Cash
The Company considers all highly liquid instruments purchased with an original maturity date of 90 days or less from the date of purchase to be cash equivalents. Management determines the appropriate classification of investments at the time of purchase and re-evaluates such determination at each balance sheet date.
Cash and cash equivalents consist of cash on deposit with banks and amounts held in interest-bearing money market funds. Cash equivalents are carried at cost, which approximates their fair market value. At both June 30, 2021 and December 31, 2020, restricted cash was $88, and related to cash held at a financial institution in an interest-bearing cash account as collateral for a letter of credit related to the contractual provisions for one of the Company’s building leases.
The following table is a reconciliation of cash, cash equivalents and restricted cash included in the accompanying condensed consolidated balance sheets that sum to the total cash, cash equivalents and restricted cash included in the accompanying condensed consolidated statements of cash flows for the six months ended June 30, 2021 and 2020.
June 30, 2021June 30, 2020
Cash and cash equivalents$180,759 $35,866 
Restricted cash included in “prepaid expenses and other current assets” and “other long-term assets,” respectively88 88 
Total cash, cash equivalents and restricted cash, at end of period$180,847 $35,954 
Concentrations of Credit Risk and Significant Customers
The Company has no off-balance sheet risk, such as foreign exchange contracts, option contracts, or other hedging arrangements. Credit losses historically have not been significant and the Company generally has not experienced any material losses related to receivables from individual customers, or
9


groups of customers. Due to these factors, no additional credit risk beyond amounts provided for collection losses is believed by management to be probable in the Company's accounts receivable.
Credit risk with respect to accounts receivable is dispersed due to the large number of customers of the Company. The Company routinely assesses the creditworthiness of its customers and generally does not require its customers to provide collateral or other security to support accounts receivable. Credit losses historically have not been significant and the Company generally has not experienced any material losses related to receivables from individual customers, or groups of customers. Due to these factors, no additional credit risk beyond amounts provided for collection losses is believed by management to be probable in the Company's accounts receivable.
As of June 30, 2021 and December 31, 2020, no individual customer represented more than 10% of the Company’s accounts receivable. During the three and six months ended June 30, 2021 and 2020, no individual customer represented more than 10% of the Company’s revenue.
Disclosure of Fair Value of Financial Instruments
The carrying amounts of the Company’s financial instruments, which include cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses, approximated their fair values at June 30, 2021 and December 31, 2020, due to the short-term nature of these instruments.
The Company has evaluated the estimated fair value of financial instruments using available market information. The use of different market assumptions and/or estimation methodologies could have a significant effect on the estimated fair value amounts. See below for further discussion.
Fair Value Measurements
ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), establishes a three-level valuation hierarchy for instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company’s own assumptions (unobservable inputs). Observable inputs are those that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances.
This guidance further identifies fair value as the exchange price, or exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants based on the highest and best use of the asset or liability. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The Company uses valuation techniques to measure fair value that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized as follows:
Level 1 inputs—Unadjusted observable quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
Level 2 inputs—Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.
Level 3 inputs—Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity.
To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the
10


degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
The Company evaluates assets and liabilities subject to fair value measurements on a recurring and nonrecurring basis to determine the appropriate level to classify them for each reporting period.
Cash equivalents include money market funds with original maturities of 90 days or less from the date of purchase. The fair value measurement of these assets is based on quoted market prices in active markets for identical assets and, therefore, these assets are recorded at fair value on a recurring basis and classified as Level 1 in the fair value hierarchy. As of June 30, 2021 and December 31, 2020, cash equivalents held in money market funds totaled $25,843 and $29,369, respectively.
As of June 30, 2021, the Company measured its investments in convertible notes (see Note 4) and its contingent consideration associated with the acquisition of Prowly.com sp. z o.o (“Prowly”) on a recurring basis using significant unobservable inputs (Level 3) and did not have any assets or liabilities measured at fair value on a recurring basis using significant other observable inputs (Level 2). As of December 31, 2020, the Company’s only recurring Level 3 fair value measurement was its contingent consideration associated with the acquisition of Prowly. Changes in fair value of the convertible notes were not material for the three and six months ended June 30, 2021. The changes in fair value of the contingent consideration associated with the Prowly acquisition were insignificant for the six months ended June 30, 2021. As of December 31, 2020, the Company did not have any assets or liabilities measured at fair value on a recurring basis using significant other observable inputs (Level 2).
Foreign Currency Translation
The Group operates in a multi-currency environment having transactions in such currencies as the U.S. dollar, Russian rubles, Czech koruna, euros, and others. The reporting currency of the Company is the U.S. dollar. The functional currency of the Company’s foreign subsidiaries is the U.S. dollar, with the exception of Prowly, where the functional currency is the local currency, the Zloty. The foreign currency translation adjustment as it relates to Prowly was immaterial for the three and six months ended June 30, 2021. For all other entities, foreign currency transactions are measured initially in the functional currency of the recording entity by use of the exchange rate in effect at that date. At each subsequent balance sheet date, foreign currency denominated assets and liabilities of these international subsidiaries are remeasured into U.S. dollars using the exchange rates in effect at the balance sheet date or historical rates, as appropriate. Any differences resulting from the remeasurement of foreign denominated assets and liabilities of the international subsidiaries to the U.S. dollar functional currency are recorded within other income (expense) in the unaudited condensed consolidated statement of operations and comprehensive loss. The foreign currency exchange gain (loss) included in other income for the three months ended June 30, 2021 and 2020 was $(53) and $(163), respectively, and $(8) and $(270) for the six months ended June 30, 2021 and 2020, respectively.
Net Income (Loss) Per Share
Net income (loss) per share information is determined using the two-class method, which includes the weighted-average number of shares of common stock outstanding during the period and other securities that participate in dividends (a participating security). Prior to the completion of the IPO, the Company considered the shares of Preferred Stock to be participating securities because they include rights to participate in dividends with the common stock. As of June 30, 2021, the Company did not have any participating securities outstanding.
Under the two-class method, basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net income (loss) per
11


share attributable to common stockholders is computed using the more dilutive of (1) the two-class method or (2) the if-converted method. The Company allocates net income first to preferred stockholders based on dividend rights under the Company’s certificate of incorporation and then to preferred and common stockholders based on ownership interests. Net losses are not allocated to preferred stockholders as they do not have an obligation to share in the Company’s net losses.
During the six months ended June 30, 2021, the Company amended its certificate of incorporation to create two classes of common stock outstanding: Class A common stock and Class B common stock. As more fully described in Note 9, the rights of the holders of Class A and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one (1) vote per share and each share of Class B common stock is entitled to ten (10) votes per share. Each share of Class B common stock is convertible into one share of Class A common stock at the option of the holder at any time. Shares of Class B common stock are automatically converted into Class A common stock upon sale or transfer, subject to certain limited exceptions. Shares of Class A common stock are not convertible. See Note 9 to these unaudited condensed consolidated financial statements for additional information regarding the current conversion and transfer terms of the Company’s common stock. The Company allocates undistributed earnings attributable to common stock between the common stock classes on a one to one basis when computing net income (loss) per share. As a result, basic and diluted net income (loss) per share of Class A common stock and share of Class B common stock are equivalent.
Diluted net income (loss) per share gives effect to all potentially dilutive securities. Potential dilutive securities consist of shares of common stock issuable upon the exercise of stock options, shares of common stock issuable upon the conversion of the outstanding shares of Preferred Stock, and shares of common stock issuable upon the vesting of restricted stock awards or restricted stock units.
For the six months ended June 30, 2021, dilutive net income per share was calculated by dividing net income by the weighted-average number of shares of common stock outstanding during the period, the dilutive impact of stock options, shares of common stock issuable upon the vesting of restricted stock units (“RSUs”), and the dilutive impact of shares issuable upon the conversion of the outstanding shares of Preferred Stock.
For the three months ended June 30, 2021 and the three and six months ended June 30, 2020, the net loss attributable to common stockholders is divided by the weighted-average number of shares of common stock outstanding during the period to calculate diluted earnings per share. The dilutive effect of common stock equivalents has been excluded from the calculation for the three months ended June 30, 2021 and the three and six months ended June 30, 2020 as their effect would have been anti-dilutive due to the net losses incurred for these periods.
The following table presents a reconciliation of the weighted-average shares outstanding used in the calculation of basic and diluted net income (loss) per share:
12


Three Months Ended June 30,Six Months Ended June 30,
2021202020212020
Weighted-average shares outstanding:
Weighted-average number of shares of common stock used in computing net income (loss) per share attributable to common stockholders—basic135,312,000 94,738,000 115,951,000 94,666,000 
Dilutive effect of share equivalents resulting from stock options  6,896,000  
Dilutive effect of share equivalents resulting from RSAs  143,000  
Dilutive effect of shares issuable upon conversion of preferred stock  14,273,000  
Weighted-average number of shares of common stock used in computing net income (loss) per share attributable to common stockholders—diluted135,312,000 94,738,000 137,263,000 94,666,000 
The following potentially dilutive common stock equivalents have been excluded from the calculation of diluted weighted-average shares outstanding for the three and six months ended June 30, 2021 and 2020:
Three Months Ended June 30,Six Months Ended June 30,
2021202020212020
Stock options outstanding6,998,703 6,374,542 1,978 6,335,830 
Shares of Preferred Stock 29,695,200  29,695,200 
Restricted stock units outstanding144,791  101,269  
7,143,494 36,069,742 103,247 36,031,030 
Comprehensive income (loss)
Comprehensive income (loss) is comprised of two components: net income (loss) and other comprehensive income (loss), which includes other changes in stockholders’ deficit that result from transactions and economic events other than those with stockholders. An immaterial cumulative translation adjustment related to the Prowly entity has been excluded from other comprehensive income for the three and six months ended June 30, 2021. There were no components of other comprehensive income to report for the three and six months ended June 30, 2020 and 2021; accordingly, comprehensive income (loss) equaled the total net income (loss) for all periods presented.
Recent Accounting Pronouncements
In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). ASU 2016-02 requires a lessee to recognize most leases on the balance sheet but recognize expenses on the income statement in a manner similar to current practice. The update states that a lessee will recognize a lease liability for the obligation to make lease payments and a right-to-use asset for the right to use the underlying assets for the lease term. Leases will continue to be classified as either financing or operating, with classification affecting the recognition, measurement, and presentation of expenses and cash flows arising from a lease. For public entities, ASU 2016-02 is effective for years beginning after December 15, 2019. For non-public companies, ASU 2016-02 is effective for fiscal years beginning after December 15, 2021 and interim periods in annual periods beginning after December 15, 2022. Early adoption is permitted. The Company plans to adopt this guidance in the year ended December 31, 2022. The Company is currently assessing the impact that adopting this guidance will have on its consolidated financial statements.
13


In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires that credit losses be reported as an allowance using an expected losses model, representing the entity's current estimate of credit losses expected to be incurred. The accounting guidance currently in effect is based on an incurred loss model. ASU 2016-13 affect loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. ASU 2016-13 is effective for public entities for annual reporting periods beginning after December 15, 2019, including interim periods within those fiscal years. For non-public companies, ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The Company plans to adopt this guidance in the year ending December 31, 2023. The Company is currently evaluating ASU 2016-13 and the potential impact on its condensed consolidated financial statements and financial statement disclosures.
In August 2018, the FASB issued ASU No. 2018-15, Intangible-Goodwill and Other Internal-Use Software (Subtopic 350-40). ASU 2018-15 updates guidance regarding accounting for implementation costs associated with a cloud computing arrangement that is a service contract. The amendments under ASU 2018-15 are effective for public entities for years beginning after December 15, 2019, and interim periods within those years. For non-public companies, ASU 2081-15 is effective for annual reporting periods beginning after December 15, 2020, and interim periods within annual periods beginning after December 15, 2021, with early adoption permitted. The Company plans to adopt this guidance in the quarter ending December 31, 2021. The Company is currently assessing the impact that adopting this guidance will have on its condensed consolidated financial statements.
In December 2019, the FASB issued ASU 2019-12, Income Taxes – Simplifying the Accounting for Income Taxes. The new guidance simplifies the accounting for income taxes by removing several exceptions in the current standard and adding guidance to reduce complexity in certain areas, such as requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. For public companies, the ASU is effective for years beginning after December 15, 2020, and interim periods within those years, with early adoption permitted. For non-public companies, the new standard is effective for years beginning after December 15, 2021, with early adoption permitted. The Company plans to adopt this guidance in the quarter ending December 31, 2021. The Company is currently assessing the impact that adopting this guidance will have on its condensed consolidated financial statements.
3.    Property and Equipment, Net
Property and equipment consists of the following (in thousands):
As of
June 30,
2021
December 31,
2020
Computer equipment$3,634 $3,513 
Furniture and office equipment1,111 1,041 
Leasehold improvements1,145 667 
Capital leases5,750  
Total property and equipment11,640 5,221 
Less: accumulated depreciation and amortization(3,244)(2,253)
Property and equipment, net$8,396 $2,968 
14


Depreciation and amortization expense related to property and equipment was $790 and $1,134 for the three and six months ended June 30, 2021, respectively, and $208 and $411 for the three and six months ended June 30, 2020, respectively.
4.    Other Long-Term Assets
Deferred Offering Costs
Deferred offering costs primarily consist of direct incremental legal and accounting fees relating to the IPO and to a credit facility. The deferred issuance costs relating to the IPO were offset against IPO proceeds upon the consummation of the Company’s offering. The deferred costs relating to the credit facility are being amortized to interest expense up through the maturity date of the facility. As of June 30, 2021 and December 31, 2020, the Company had deferred offering costs relating to the IPO of $0 and $1,839. As of June 30, 2021 and December 31, 2020, the Company had $526 and $630, respectively, in issuance costs relating to the credit facility. The issuance costs for the IPO and credit facility are classified in other long-term assets in the accompanying unaudited condensed consolidated balance sheets.
Investments in Convertible Debt
In January 2021, the Company purchased two convertible debt securities for a total aggregate investment of $500. Both investments mature on January 1, 2023 and receive interest at an annual rate of 6%. Interest accrues and becomes payable upon conversion of the convertible notes, or will be paid in connection with the repayment in full of the principal amount of such convertible notes.
These convertible note investments are classified as available-for-sale securities and are classified in other long-term assets in the accompanying unaudited condensed consolidated balance sheets based on the maturity date. The Company accounts for these investments, along with the embedded derivatives associated with their conversion features, by utilizing the fair value option within ASC 825 and accounting for the entire hybrid instrument at fair value through earnings. Changes in fair value of the convertible notes were not material for the three and six months ended June 30, 2021.

5.    Acquisitions, Acquired Intangible Assets, and Goodwill
Acquisitions
On August 27, 2020, the Company acquired 100% of the outstanding capital of Prowly for cash consideration of $3,317. In addition to the purchase consideration, the founders of Prowly are eligible to earn up to a maximum of $2,750 in aggregate additional consideration based on the satisfaction of certain earnings targets as defined in the purchase agreement. For the three and six months ended June 30, 2021, the Company recognized compensation expense of $57 and $113, respectively, as compensation expense related to the additional consideration.
Intangible Assets
Intangible assets consisted of intangible assets resulting from the acquisition of Prowly and capitalized internal-use software development costs. Intangible assets consists of the following:

15


As of June 30, 2021
GrossNet
CarryingAccumulatedCarrying
AmountAmortizationAmount
Developed technology1,194 (166)1,028 
Trade name68 (19)49 
Capitalized internal-use software1,828 (778)1,050 
Total as of June 30, 2021
$3,090 $(963)$2,127 
As of December 31, 2020
GrossNet
CarryingAccumulatedCarrying
AmountAmortizationAmount
Developed technology1,194 (66)1,128 
Trade name68 (3)65 
Capitalized internal-use software1,561 (523)1,038 
Total as of December 31, 2020
$2,823 $(592)$2,231 

During the three and six months ended June 30, 2021, the Company capitalized $144 and $271, respectively, of software development costs, which are classified as intangible assets on the accompanying consolidated balance sheets. During the three and six months ended June 30, 2020, the Company capitalized $403 and $603, respectively, of software development costs. The Company recorded amortization expense associated with its capitalized development costs of $130 and $259 for the three and six months ended June 30, 2021, respectively. The Company recorded amortization expense associated with its capitalized development costs of $52 and $104 for the three and six months ended June 30, 2020, respectively. As of June 30, 2021 and December 31, 2020, the capitalized internal-use software asset balances totaled $1,050 and $1,038, respectively.
Amortization expense for acquired intangible assets was $55 and $116 for the three and six months ended June 30, 2021. There was no amortization expense for acquired intangible assets for the three and six months ended June 30, 2020.
As of June 30, 2021, future amortization expense is expected to be as follows:
Amount
Remainder of 2021$334 
2022559 
2023428 
2024199 
2025 and thereafter
607 
Total$2,127 
Goodwill
The was no change in the carrying value of goodwill of $1,991 from December 31, 2020 through June 30, 2021.

16


6.    Accrued expenses
Accrued expenses consist of the following:
As of
June 30,
2021
December 31,
2020
Employee compensation$5,847 $4,478 
Vacation reserves464 465 
Other6,536 2,776 
Total accrued expenses$12,847 $7,719 

7.     Revolving Credit Facility
Senior Secured Revolving Credit Facility
On January 12, 2021, the Company executed a credit agreement with JPMorgan Chase Bank, N.A., in the form of a revolving credit facility, that consists of a $45.0 million revolving credit facility and a letter of credit sub-facility with an aggregate limit equal to the lesser of $5.0 million and the aggregate unused amount of the revolving commitments then in effect. The availability of the credit facility is subject to the borrowing base based on an advance rate of 400% multiplied by annualized retention applied to monthly recurring revenue. The credit facility has a maturity of three years and will mature on January 12, 2024.
Borrowings under the credit facility bear interest at the Company’s option at (i) LIBOR, subject to a 0.50% floor, plus a margin, or (ii) the alternate base rate, subject to a 3.25% floor (or 1.50% prior to positive consolidated adjusted earnings before interest, taxes, depreciation, and amortization (“adjusted EBITDA”) for the twelve months most recently ended), plus a margin. For LIBOR borrowings, the applicable rate margin is 2.75% (or 3.50% prior to positive consolidated adjusted EBITDA as of the twelve months most recently ended). For base rate borrowings, the applicable margin is 0.00% (or 2.50% prior to positive consolidated adjusted EBITDA as of the twelve months most recently ended). The Company is also required to pay a 0.25% per annum fee on undrawn amounts under the Company’s revolving credit facility, payable quarterly in arrears.
As of June 30, 2021, the Company has not drawn on this revolving credit facility. For the three and six months ended June 30, 2021, the Company incurred $28 and $53 in interest expense, respectively, relating to this credit facility.

8.    Income Taxes
We are subject to U.S. federal, state, and foreign income taxes. For the three and six months ended June 30, 2021, we recorded provisions for income taxes of $141 and $227, respectively. For the three and six months ended June 30, 2020, we recorded provisions for income taxes of $92 and $208, respectively. Our effective tax rate for the six months ended June 30, 2021 and 2020 differs from the U.S. statutory rate primarily due to the jurisdictional mix of earnings and the valuation allowance maintained against our net deferred tax assets.
We recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities. These differences are measured using the enacted statutory tax rates that are expected to be in effect for the years in which differences are expected to reverse. On a periodic basis, we reassess any valuation
17


allowances that we maintain on our deferred tax assets, weighing positive and negative evidence to assess the recoverability of the deferred tax assets. We maintain a valuation allowance on certain federal, state, and foreign tax attributes that are not more-likely-than-not realizable.

9.    Redeemable Convertible Preferred Stock and Stockholders’ Equity
Prior to the IPO, the authorized capital stock of the Company included 9,898,400 shares of preferred stock, of which 3,379,400 shares have been designated as Series A Redeemable Convertible Preferred Stock, 1,837,600 shares have been designated as Series A-1 Redeemable Convertible Preferred Stock and 4,681,400 shares have been designated as Series B Convertible Preferred Stock (collectively the “Preferred Stock”).
Immediately prior to the closing of the IPO, the outstanding shares of Preferred Stock were converted on a three-for-one basis into 29,695,200 shares of common stock. The holders of the Company’s Preferred Stock had certain voting, dividend, and redemption rights, as well as liquidation preferences and conversion privileges. All rights, preferences, and privileges associated with the preferred stock were terminated at the time of the Company’s IPO in conjunction with the conversion of all outstanding shares of Preferred Stock into shares of common stock.
As of June 30, 2021, the total number of shares of all classes of stock which the Company shall have authority to issue was (i) 1,000,000,000 shares of Class A common stock, par value $0.00001 per share, and (ii) 160,000,000 shares of Class B common stock, par value $0.00001 per share, and (iii) 100,000,000 undesignated shares of Preferred Stock, par value $0.00001 per share.
Each share of Class A common stock entitles the holder to one vote for each share on all matters submitted to a vote of the Company's stockholders at all meetings of stockholders and written actions in lieu of meetings. Each share of Class B common stock entitles the holder to ten votes for each share on all matters submitted to a vote of the Company's stockholders at all meetings of stockholders and written actions in lieu of meetings.
Holders of Class A common stock and Class B common stock are entitled to receive dividends, when and if declared by the board of directors (the “Board”).
Each share of Class B common stock is convertible into one share of Class A common stock at the option of the holder at any time. Automatic conversion shall occur upon the occurrence of (i) a Transfer, as defined in the amended and restated certificate of incorporation, of such share of Class B common stock, (ii) the affirmative vote of at least two-thirds of the outstanding shares of Class B common stock, voting as a single class, or (iii) on or after the earlier to occur of (a) the seventh year anniversary of the effectiveness of the amended and restated certificate of incorporation or (b) the date on which the outstanding shares of Class B common stock represents less than 10% of the aggregate number of the then outstanding shares of Class A common stock and Class B common stock. Further, upon either the death or incapacitation of a holder of Class B common stock, the shares held by such shareholder shall automatically be converted into one share of Class A common stock.
Stock Split
On March 15, 2021, the Board approved a 3-for-1 stock-split of the Company’s common stock. The stock split was approved by the stockholders on March 15, 2021 and became effective on March 15, 2021. Upon the effectiveness of the stock split, (i) every one share of common stock outstanding was increased to 3 shares of common stock, (ii) the number of shares of common stock into which each outstanding option to purchase common stock is exercisable was proportionally increased on a 3-for-1 basis, and (iii) the exercise price of each outstanding option to purchase common stock was proportionately decreased on a 3-for-1 basis. Additionally, shares of common stock reserved for issuance
18


upon the conversion of the Company’s Preferred Stock were proportionately increased on a 3-for-1 basis and the respective conversion prices of the Preferred Stock were proportionately reduced. All share and per share data shown in the accompanying consolidated financial statements and related notes have been retroactively revised to reflect the stock split.
Common Stock Reserved for Future Issuance
As of June 30, 2021, the Company had reserved the following shares of common stock for future issuance:
Options outstanding7,756,641 
Options reserved for future issuance13,135,939 
Restricted stock outstanding156,852 
Restricted stock units155,025 
Total authorized shares of common stock reserved for future issuance 21,204,457 
n
]
10.    Stock-Based Compensation
In 2019, the Board adopted the Semrush Holdings, Inc. 2019 Stock Option and Grant Plan (the “2019 Plan”), which provides for the grant of qualified incentive stock options and nonqualified stock options or other awards, including restricted stock unit awards, to the Company’s employees, officers, directors, advisors, and outside consultants for the purchase of up to 8,682,600 shares of the Company’s common stock. In July 2020, the Plan was amended to provide for the grant of qualified incentive stock options and nonqualified stock options or other awards to the Company’s employees, officers, directors, advisors, and outside consultants for the purchase of up to 10,163,772 shares of the Company’s common stock. Stock options generally vest over a 4 year period and expire 10 years from the date of grant. Certain options provide for accelerated vesting if there is a change in control (as defined in the Plan).
The Semrush Holdings, Inc. 2021 Stock Option and Incentive Plan (the “2021 Plan”) was adopted by the Board March 3, 2021 and approved by stockholders on March 15, 2021 and became effective immediately prior to the effectiveness of the Company’s registration statement in connection with its IPO. The 2021 Plan replaced the 2019 Plan as the Board determined not to make additional awards under the 2019 Plan following the pricing of the Company’s IPO. The 2021 Plan allows the compensation committee of the Board to make equity-based and cash-based incentive awards to the Company’s officers, employees, directors and other key persons (including consultants).
The Company initially reserved 13,503,001 shares of Class A common stock for the issuance of awards under the 2021 Plan. The 2021 Plan provides that the number of shares reserved and available for issuance under the plan will automatically increase each January 1, beginning on January 1, 2022, by the lesser of 5% of the outstanding number of shares of Class A and Class B common stock on the immediately preceding December 31, or such lesser number of shares as determined by the compensation committee. This number is subject to adjustment in the event of a stock split, stock dividend or other change in our capitalization.
The Company accounts for stock-based compensation in accordance with the provisions of ASC 718, which requires the recognition of expense related to the fair value of stock-based compensation awards in the statements of operations. For stock-based awards issued under the Company’s stock-based compensation plans to employees and members of the Board for their services on the Board, the fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model as discussed further below. For RSUs granted subject to service-based vesting conditions, the fair value is determined based on the closing price of the Company’s Class A common stock, as reported on the New York Stock Exchange on the date of grant. RSUs granted subject to service-based vesting
19


conditions generally vest over a four-year requisite service period. For all other service-based awards, the Company recognizes compensation expense on a straight-line basis over the requisite service period of the award with actual forfeitures recognized as they occur.
Given the absence of an active market for the Company’s common stock prior to the completion of the IPO, the Board, the members of which the Company believes have extensive business, finance, and venture capital experience, were required to estimate the fair value of the Company’s common stock at the time of each grant of a stock-based award. The Company and the Board utilized various valuation methodologies in accordance with the framework of the American Institute of Certified Public Accountants’ Technical Practice Aid, Valuation of Privately-Held Company Equity Securities Issued as Compensation, to estimate the fair value of its common stock. Each valuation methodology included estimates and assumptions that require the Company’s judgment. These estimates and assumptions include a number of objective and subjective factors, in determining the value of the Company’s common stock at each grant date, including the following factors: (1) prices paid for the Company’s Preferred Stock, which the Company had sold to outside investors in arm’s-length transactions, and the rights, preferences, and privileges of the Company’s Preferred Stock and common stock; (2) valuations performed by an independent valuation specialist; (3) the Company’s stage of development and revenue growth; (4) the fact that the grants of stock-based awards involved illiquid securities in a private company; and (5) the likelihood of achieving a liquidity event for the common stock underlying the stock-based awards, such as an IPO or sale of the Company, given prevailing market conditions.
The Company believes this methodology to be reasonable based upon the Company’s internal peer company analyses, and further supported by several arm’s-length transactions involving the Company’s Preferred Stock. As the Company’s common stock is not actively traded, the determination of fair value involves assumptions, judgments, and estimates. If different assumptions were made, stock-based compensation expense, consolidated net income (loss) and consolidated net income (loss) per share could have been significantly different.
The Company has recorded stock-based compensation expense of $569 and $1,162 during the three and six months ended June 30, 2021, respectively, and recorded $209 and $414 for the three and six months ended June 30, 2020, respectively. The following table shows stock-based compensation expense by where the stock-based compensation expense is recorded in the Company’s unaudited condensed consolidated statement of operations:
Three Months Ended
June 30,
Six Months Ended
June 30,
2021202020212020
Cost of revenue
$7 $5 $14 $9 
Sales and marketing
52 27 242 64 
Research and development
68 29 135 58 
General and administrative
442 148 771 283 
Total stock-based compensation
$569 $209 $1,162 $414 
As of June 30, 2021, there was $5,581 of unrecognized compensation cost related to unvested common stock option arrangements granted under the 2021 Plan, which is expected to be recognized over a weighted-average period of 3.07 years.
The fair value of each option award was estimated on the date of grant using the Black-Scholes option-pricing model. As there was no public market for its common stock prior to March 25, 2021, which was the first day of trading, and as the trading history of the Company’s common stock was limited through March 31, 2021, the Company determined the expected volatility for options granted based on an analysis of reported data for a peer group of companies that issued options with substantially similar
20


terms. The expected volatility of options granted has been determined using an average of the historical volatility measures of this peer group of companies. The expected life of options granted to employees was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted-average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate expected term. The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected life of the share option. The Company has not paid, nor anticipates paying, cash dividends on its ordinary shares; therefore, the expected dividend yield is assumed to be zero.
The weighted-average assumptions utilized to determine the fair value of options granted to employees are presented in the following table:
Three Months Ended June 30,Six Months Ended June 30,
2021202020212020
Expected volatility52.0 %51.2 %52.0 %48.3 %
Weighted-average risk-free interest rate1.13 %0.42 %1.04 %1.09 %
Expected dividend yield    
Expected life – in years6666
A summary of the Company’s option activity as of June 30, 2021, which all occurred under the 2019 Plan and the 2021 Plan, and changes during the six months then ended are as follows:
Number of OptionsWeighted-Average Exercise Price (per share)Weighted-Average Remaining Contractual Term (in years)
Outstanding at December 31, 2020
7,611,258 $1.37 8.40
Granted229,053 12.37 
Exercised(33,327)1.25 
Forfeited(50,343)2.00 
Outstanding at June 30, 2021
7,756,641 1.69 8.07
Options exercisable at June 30, 2021
3,680,766 0.977.52
The weighted-average grant-date fair value of options granted during the three and six months ended June 30, 2021 was $6.69 and $6.13 per share, respectively. The weighted-average grant-date fair value of options granted during the three and six months ended June 30, 2020 was $0.80 and $0.65 per share, respectively. No tax benefits were realized from options during the three and six months ended June 30, 2021 or 2020.
The aggregate intrinsic value of options outstanding as of June 30, 2021 and December 31, 2020 was $165,416 and $36,816, respectively.
The aggregate intrinsic value for options exercised during the three and six months ended June 30, 2021 was $473 and $492.
The aggregate intrinsic value for options exercisable as of June 30, 2021 was $81,164.
The aggregate intrinsic value was calculated based on the positive difference, if any, between the estimated fair value of the Company’s common stock on June 30, 2021 and December 31, 2020, respectively, or the date of exercise, as appropriate, and the exercise price of the underlying options.
21


On July 28, 2020, the Company issued 156,852 shares of its restricted common stock (“Restricted Stock Issuance”) to the founders of Prowly for a total fair value of $291 under the 2019 Plan. This Restricted Stock Issuance vests over a three-year service period, applicable to both founders.
During the three and six months ended June 30, 2021, the Company granted to employees RSU awards for 96,525 and 155,025 shares of Class A common stock under the 2021 Plan, respectively. The Company recorded stock-based compensation expense related to the RSU grants of $120 and $145, respectively. The Company granted no RSU awards during the six months ended June 30, 2020; accordingly, there was no RSU compensation expense associated with this periods.
A summary of RSU activity under the Company’s 2021 Plan for the six months ended June 30, 2021 is as follows: